Pennington, NJ, United States of America

Alan R DeAngelis

This inventor holds 10 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignees: Janssen Pharmaceutica Nv, Fmc Corporation. Active years: 1999-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alan R DeAngelis. Retrieved from https://idiyas.com/inventor/alan-r-deangelis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 70.0


Average Co-Inventor Count = 3.9

ph-index = 4

Forward Citations = 93(Granted Patents)


Company Filing History:


Years Active: 1999-2017

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: **Innovator Spotlight: Alan R DeAngelis**

Introduction

Alan R DeAngelis is an accomplished inventor based in Pennington, NJ, USA, known for his significant contributions to the field of pharmaceuticals. With a total of 10 patents to his name, DeAngelis has made notable advancements in the development of innovative compounds that have the potential to improve human health and treat various conditions.

Latest Patents

Among his latest inventions are the 4-(phenoxyalkyl)thio)-phenoxyacetic acids and their analogs. This invention features compositions containing these compounds and outlines methods of using them as PPAR delta modulators to treat or inhibit the progression of dyslipidemia, a medical condition that can result in cardiovascular issues. The innovation represents a promising advancement in therapeutic strategies for managing lipid disorders.

Career Highlights

Throughout his career, Alan R DeAngelis has worked with esteemed organizations such as Janssen Pharmaceutica NV and FMC Corporation. His experiences at these companies have undoubtedly contributed to his innovative mindset and understanding of pharmaceutical development and research.

Collaborations

DeAngelis has collaborated with several talented individuals in the field, most notably with colleagues Gee-Hong Kuo and Rui Zhang. These partnerships have fostered a rich environment for idea exchange and innovation, enhancing the overall impact of their work.

Conclusion

Alan R DeAngelis exemplifies the spirit of innovation through his contributions to pharmaceutical invention and development. With his remarkable achievements and ongoing dedication to advancing medical treatments, he continues to leave a significant mark on the industry. The future looks promising as he continues to explore new avenues for impactful innovations in health and well-being.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…